Clinical Trial Update: Vitamin D3 in Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results explore the effects of vitamin D3 (cholecalciferol) in patients with systemic lupus erythematosus (SLE).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Systemic Lupus Erythematosus, SLE | Phase 2 | Status: COMPLETED | Results posted: 2014-04-25